Archives for June 7, 2006

← 2006

Werum passes management test

By  staff reporter

Werum Software & Systems has updated its manufacturing execution systems (MES) for the pharmaceutical and biopharmaceutical industry, enhancing process reliability and cost effectiveness.

Hovione passes 'most thorough and effective FDA inspection ever'

By  Gregory Roumeliotis

Fine chemicals company Hovione has passed an inspection by the US Food and Drug Administration (FDA) at its active pharmaceutical ingredient (API) manufacturing site in Loures, Portugal, as it tries to conform with ever-stricter standards.

Beckman Coulter launches improved IM test

By  Wai Lang Chu

A new one-step test that is designed to distinguish heterophile-positive, infectious mononucleosis (IM) from other common symptomatic infections, claims to deliver a 99 per cent sensitivity score, significantly improving on current methods.

Gilead buys Degussa's API custom manufacturing unit

By  Gregory Roumeliotis

Biotechnology firm Gilead has acquired Raylo Chemicals, a Canadian production unit of active pharmaceutical ingredients (APIs) and advanced intermediates, from Degussa for €115m, seeking to bring more manufacturing capacity and expertise in-house.

Jacobs wins two pharma engineering contracts

By  Kirsty Barnes

Jacobs Engineering Group has been chosen to upgrade and expand GlaxoSmithKline's (GSK) manufacturing capability at its Irish plant, as well as develop a new biological manufacturing facility for US firm Northfield Laboratories.

SurModics technology gives edge to new drug-eluting stent

By  Kirsty Barnes

SurModics has licensed its advanced hydrophilic coating technology to Xtent for use in the delivery system of its novel drug-eluting stent (DES) system, designed to reduce the time, complexity and cost of coronary stent procedures.

Outsourcing-Pharma.com focus on: cutting the cost of clinical trials

What can CROs do to keep Indian clinical trials ethical?

By  Kirsty Barnes

Outsourcing-Pharma takes a look at how clinical research organisations (CROs) operating in India can do their best to ensure that clinical trials in the region are carried out ethically.

SGS moves to cash in on Chinese contract testing

By  Kirsty Barnes

After recently opening up shop in nearby Singapore, SGS has now brought its contract testing services to neighbouring China to continue to cash in on the demand for such services in the Asia-Pacific region.